Australian Clinical Labs Limited (ASX:ACL)

Australian Clinical Labs Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	737.49	741.27	696.37	697.07	995.6	646.7
Revenue Growth (YoY)	1.27%	6.45%	-0.10%	-29.98%	53.95%	31.83%
Cost of Revenue	467.32	470.41	442.37	445.45	546.98	390.18
Gross Profit	270.17	270.86	254	251.62	448.62	256.53
Amortization of Goodwill & Intangibles	0.24	0.23	0.23	0.23	0.23	0.03
Other Operating Expenses	66.6	66.81	63.02	63.65	68.54	40.47
Operating Expenses	201.53	202.86	191.45	186.4	174.64	128.53
Operating Income	68.65	68	62.55	65.22	273.98	128
Interest Expense	-14.39	-14.59	-12.18	-13.47	-11.75	-15.13
Interest & Investment Income	0.39	0.41	0.5	0.18	0.05	0.08
Other Non Operating Income (Expenses)	-3.34	-3.78	-4.86	-0.4	-	-18.46
EBT Excluding Unusual Items	51.3	50.05	46.01	51.53	262.28	94.49
Merger & Restructuring Charges	-1.62	-3.08	-6.17	-2.63	-8.94	-
Other Unusual Items	-2.03	-	-4.65	-3.28	-	-7.83
Pretax Income	41.63	48.18	36.37	48.31	254.9	86.65
Income Tax Expense	14.93	15.36	12.12	12.27	76.5	26.26
Earnings From Continuing Operations	26.7	32.82	24.24	36.04	178.4	60.39
Minority Interest in Earnings	-0.39	-0.39	-0.31	-0.14	-0.16	-0.02
Net Income	26.31	32.43	23.93	35.9	178.24	60.37
Net Income to Common	26.31	32.43	23.93	35.9	178.24	60.37
Net Income Growth	-14.22%	35.50%	-33.33%	-79.86%	195.24%	46.34%
Shares Outstanding (Basic)	186	189	199	201	201	152
Shares Outstanding (Diluted)	187	190	199	201	201	152
Shares Change (YoY)	-6.50%	-4.63%	-0.82%	-0.18%	32.47%	4.65%
EPS (Basic)	0.14	0.17	0.12	0.18	0.89	0.40
EPS (Diluted)	0.14	0.17	0.12	0.18	0.88	0.40
EPS Growth	-8.21%	42.09%	-32.77%	-79.82%	122.88%	39.83%
Free Cash Flow	156.7	174.39	153.09	136.75	262.84	144.36
Free Cash Flow Per Share	0.84	0.92	0.77	0.68	1.30	0.95
Dividend Per Share	0.128	0.125	0.120	0.140	0.530	0.142
Dividend Growth	2.00%	4.17%	-14.29%	-73.58%	271.93%	-1.38%
Gross Margin	36.63%	36.54%	36.48%	36.10%	45.06%	39.67%
Operating Margin	9.31%	9.17%	8.98%	9.36%	27.52%	19.79%
Profit Margin	3.57%	4.38%	3.44%	5.15%	17.90%	9.34%
Free Cash Flow Margin	21.25%	23.53%	21.98%	19.62%	26.40%	22.32%
EBITDA	81.58	81.36	76.31	79.71	286.36	138.19
EBITDA Margin	11.06%	10.98%	10.96%	11.43%	28.76%	21.37%
D&A For EBITDA	12.93	13.35	13.76	14.49	12.37	10.19
EBIT	68.65	68	62.55	65.22	273.98	128
EBIT Margin	9.31%	9.17%	8.98%	9.36%	27.52%	19.79%
Effective Tax Rate	35.87%	31.88%	33.33%	25.39%	30.01%	30.31%
Revenue as Reported	738.07	742.49	697.54	704.76	997.17	644.67

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.